Oruka Therapeutics, Inc.
ORKA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30 | -$25 | -$21 | -$26 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $5 | $0 | $0 |
| Change in WC | $2 | -$2 | -$3 | $4 |
| Other Non-Cash | $7 | -$1 | $3 | $3 |
| Operating Cash Flow | -$22 | -$23 | -$21 | -$19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$108 | -$44 | $0 |
| Inv. Sales/Matur. | $0 | $113 | $87 | $0 |
| Other Inv. Act. | -$122 | $0 | $0 | -$330 |
| Investing Cash Flow | -$122 | $5 | $43 | -$330 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $29 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $170 | $0 | $0 | -$30 |
| Financing Cash Flow | $170 | $0 | $0 | -$1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $26 | -$18 | $22 | -$349 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $65 | $84 | $62 | $411 |
| End Cash | $91 | $65 | $84 | $62 |
| Free Cash Flow | -$22 | -$23 | -$21 | -$19 |